Introduction of Drug Exclusivity in China Marks New Era for Drug Innovation
Powered by ![]()
All the vital news, analysis, and commentary curated by our industry experts.
$2995
China is shifting from a generic manufacturing base to a global hub for new drug innovation. This transition is increasing the need to strengthen the patent protection system, and data exclusivity will finally be introduced in China soon.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
See what our customers are saying
Related reports
View more Product Type reports
New
New
New